Haitang Yang

16PUBLICATIONS
31CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 05, 2026
HMGCS1 drives cholesterol-dependent membrane repair and shields tumor cells from lymphocyte attack.

|Apr 14, 2026
Photoactivatable Cascade DNAzyme Nanomachines for Amplified Imaging of Tumor Response to STING-Activated Immunotherapy.

Jiajia Pan, Haojie Wu, Yunxuan Chou

|Dec 06, 2024
Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer.

Liang Zhao, Haibin Deng, Jingyi Zhang

|Oct 24, 2024
Predicting non-small cell lung cancer lymph node metastasis: integrating ctDNA mutation/methylation profiling with positron emission tomography-computed tomography (PET-CT) scan: protocol for a prospective clinical trial (LUNon-invasive Study).

Haitang Yang, Xiaoran Gu, Zhexin Wang

|Feb 10, 2023
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma.

Haitang Yang, Yanyun Gao, Duo Xu

|Aug 09, 2021
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer.

Zhang Yang, Shun-Qing Liang, Maria Saliakoura

Pageof 3

Frequent Collaborators

8 joint publications

Ren-Wang Peng

7 joint publications

Ralph A Schmid

5 joint publications

Thomas M Marti

3 joint publications

Feng Yao